Single-cell multi-omics analyses reveal dysfunctional immune responses in patients with post-acute COVID-19 sequelae

Chang, De, Zhu, Zhipeng, Zhu, Rongyi, Song, Ying, Xiao, Zhiqing, Wu, Chunting, Li, Xuehui, Zhu, Ying, Guo, Peiyan, Liu, Hongwu, Li, Dandan, Zhang, Hong, Wang, Fei, Su, Yinglong, Li, Jiandong, Zhang, Mi, Zhang, Qing, Zhao, Xiaolu, Liu, Yuying, Sharma, Lokesh, Xie, Lixin, Mao, Fengbiao, Li, Kailong
Marine Life Science & Technology · Springer Nature · 2026-11-06 · DOI: 10.1007/s42995-026-00431-z

Аннотация

Millions of individuals experience prolonged symptoms following the acute phase of SARS‐CoV‐2 infection, known as post-acute sequelae of COVID-19 (PASC), but the mechanistic basis remains poorly understood. In this study, we used single-cell RNA sequencing (scRNA-seq) to determine the immunological landscape of peripheral blood samples from patients with COVID-19 with viral persistence (VP) and pulmonary fibrosis (PF). In conjunction with B-cell receptor profiling and mass cytometry (CyTOF) analyses, we found that patients with VP had systemic inflammation and dysregulation of the innate immune cells, including global deficiency and dysfunction relating to antiviral activity, inflammatory responses, and antigen presentation. In contrast, molecular features were substantially different in patients with PF. Specifically, we observed evidence for an immune-megakaryocyte subpopulation expansion in patients with PF. The immune-megakaryocyte facilitated PF by expanding and reinforcing antigen-presenting activity, which emphasized the important role of antigen-presenting cells in PASC. Further, analyses demonstrated reduced T and B-cell immune activation in patients with VP and hyperactive CD4^+ T and B-cell status in patients with PF. These findings illustrate the dynamic nature of both innate and adaptive immune responses during PASC development, explaining the underlying pathogenesis and illuminating potential therapeutic targets in PASC.

Читать у издателя →

Похожие статьи